|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismEPHB3 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hedgehog Co., Ltd.
0 Patents (Medical) associated with Hedgehog Co., Ltd.
100 Deals associated with Hedgehog Co., Ltd.
100 Translational Medicine associated with Hedgehog Co., Ltd.